Aristides Polyzos

Clinical Features of Hypersensitivity Reactions to Oxaliplatin: A 10-Year Experience

Aristides Polyzos, Nikolas Tsavaris, Hellen Gogas et al. · Oncology · 2008 · 106 citations

FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG)

Aristides Polyzos, Nikolaos Malamos, Ioannis Boukovinas et al. · Breast Cancer Research and Treatment · 2009 · 42 citations · Full text

Breast Oncology, Oncology, Randomized Study +8

A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer

Zacharenia Saridaki, Nikolaos Malamos, Panagiotis Kourakos et al. · Cancer Chemotherapy and Pharmacology · 2011 · 32 citations

Metastatic Breast Cancer, Oncology, Breast Oncology +9

Docetaxel in combination with irinotecan (CPT-11) in platinum-resistant paclitaxel-pretreated ovarian cancer.

Aristides Polyzos, Christos Kosmas, Helen Toufexi et al. · PubMed · 2005 · 20 citations

Combination Chemotherapy, Rhg-csf Support, Endocrine-related Cancer +13

Salvage chemotherapy with oxaliplatin and capecitabine for breast cancer patients pretreated with anthracyclines and taxanes.

Aristides Polyzos, Helen Gogas, Christos Markopoulos et al. · PubMed · 2009 · 12 citations

Salvage Chemotherapy, Breast Oncology, Oncology +12